DK398887A - Antistoffer - Google Patents

Antistoffer

Info

Publication number: DK398887A
Authority: DK; Denmark
Prior art keywords: antibodies
Prior art date: 1986-07-30

Application number

DK398887A

Other languages

English (en)

Other versions

DK398887D0 (da

Inventor

Yushi Nishimura

Yataro Ichikawa

Akira Kudo

Takeshi Watanabe

Original Assignee

Teijin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-07-30

Filing date

1987-07-30

Publication date

1988-01-31

1986-07-30 Priority claimed from JP61177809A external-priority patent/JPS6336795A/ja

1986-07-31 Priority claimed from JP61178881A external-priority patent/JPS6336786A/ja

1986-08-01 Priority claimed from JP61180194A external-priority patent/JPH0698021B2/ja

1987-07-30 Application filed by Teijin Ltd filed Critical Teijin Ltd

1987-07-30 Publication of DK398887D0 publication Critical patent/DK398887D0/da

1988-01-31 Publication of DK398887A publication Critical patent/DK398887A/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Hematology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DK398887A 1986-07-30 1987-07-30 Antistoffer DK398887A (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP61177809A JPS6336795A (ja)	1986-07-30	1986-07-30	新規アミノ酸配列及び核酸塩基配列
JP61178881A JPS6336786A (ja)	1986-07-31	1986-07-31	抗体ｌ鎖発現型核酸塩基配列，プラスミド，細胞及びキメラ抗体ｌ鎖
JP61180194A JPH0698021B2 (ja)	1986-08-01	1986-08-01	マウス−ヒトキメラ抗体、それをコ−ドする発現型キメラｄｎａ配列、プラスミド及び細胞

Publications (2)

Publication Number	Publication Date
DK398887D0 DK398887D0 (da)	1987-07-30
DK398887A true DK398887A (da)	1988-01-31

Family

ID=27324481

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK398887A DK398887A (da)	1986-07-30	1987-07-30	Antistoffer

Country Status (3)

Country	Link
EP (1)	EP0255694A1 (da)
DK (1)	DK398887A (da)
NO (1)	NO873164L (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US5336603A (en) *	1987-10-02	1994-08-09	Genentech, Inc.	CD4 adheson variants
US6710169B2 (en)	1987-10-02	2004-03-23	Genentech, Inc.	Adheson variants
US5116964A (en)	1989-02-23	1992-05-26	Genentech, Inc.	Hybrid immunoglobulins
US6797492B2 (en)	1991-05-17	2004-09-28	Merck & Co., Inc.	Method for reducing the immunogenicity of antibody variable domains
AU669124B2 (en) *	1991-09-18	1996-05-30	Kyowa Hakko Kirin Co., Ltd.	Process for producing humanized chimera antibody
WO1993013133A1 (en) *	1991-12-20	1993-07-08	Yamanouchi Pharmaceutical Co., Ltd.	HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa
US5777085A (en) *	1991-12-20	1998-07-07	Protein Design Labs, Inc.	Humanized antibodies reactive with GPIIB/IIIA
US5635177A (en)	1992-01-22	1997-06-03	Genentech, Inc.	Protein tyrosine kinase agonist antibodies
ATE237353T1 (de) *	1992-05-05	2003-05-15	Aeres Biomedical Ltd	Antikörper gegen p-selectin und ihre verwendung
US6033667A (en) *	1992-05-05	2000-03-07	Cytel Corporation	Method for detecting the presence of P-selectin
US5877016A (en)	1994-03-18	1999-03-02	Genentech, Inc.	Human trk receptors and neurotrophic factor inhibitors
CU22615A1 (es)	1994-06-30	2000-02-10	Centro Inmunologia Molecular	Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
US6100071A (en)	1996-05-07	2000-08-08	Genentech, Inc.	Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
UA76934C2 (en)	1996-10-04	2006-10-16	Chugai Pharmaceutical Co Ltd	Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
TWI353991B (en)	2003-05-06	2011-12-11	Syntonix Pharmaceuticals Inc	Immunoglobulin chimeric monomer-dimer hybrids
CN1871259A (zh)	2003-08-22	2006-11-29	比奥根艾迪克Ma公司	具有改变的效应物功能的经改进的抗体和制备它的方法
US8354507B2 (en)	2003-12-15	2013-01-15	Dendreon Corporation	HLA-DR specific antibodies, compositions and methods
RS20070027A (en)	2004-07-26	2008-11-28	Biogen Idec Ma Inc.,	Anti-cd154 antibodies
PT1866339E (pt)	2005-03-25	2013-09-03	Gitr Inc	Moléculas de ligação a gitr e suas utilizações
ES2547463T3 (es)	2005-06-17	2015-10-06	Merck Sharp & Dohme Corp.	Moléculas de unión a ILT3 y usos de las mismas
AU2007345745C1 (en)	2006-06-19	2013-05-23	Merck Sharp & Dohme Corp.	ILT3 binding molecules and uses therefor
WO2009009116A2 (en)	2007-07-12	2009-01-15	Tolerx, Inc.	Combination therapies employing gitr binding molecules
EA201291482A1 (ru)	2010-07-09	2013-10-30	Байоджен Айдек Хемофилия Инк.	Химерные факторы коагуляции
WO2012170969A2 (en)	2011-06-10	2012-12-13	Biogen Idec Ma Inc.	Pro-coagulant compounds and methods of use thereof
US9738707B2 (en)	2011-07-15	2017-08-22	Biogen Ma Inc.	Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto
HUE039033T2 (hu)	2012-01-10	2018-12-28	Biogen Ma Inc	Terápiás molekulák transzportjának fokozása a vér-agy gáton keresztül
WO2015070014A1 (en)	2013-11-08	2015-05-14	Biogen Idec Ma Inc.	Procoagulant fusion compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61134325A (ja) *	1984-12-04	1986-06-21	Teijin Ltd	ハイブリツド抗体遺伝子の発現方法

1987
- 1987-07-28 NO NO873164A patent/NO873164L/no unknown
- 1987-07-29 EP EP87110994A patent/EP0255694A1/en not_active Withdrawn
- 1987-07-30 DK DK398887A patent/DK398887A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO873164L (no)	1988-02-01
NO873164D0 (no)	1987-07-28
EP0255694A1 (en)	1988-02-10
DK398887D0 (da)	1987-07-30

Publication	Publication Date	Title
DK398887D0 (da)	1987-07-30	Antistoffer
AT399804B (de)	1995-07-25	Sportschuh
BR8705670A (pt)	1988-05-31	Fecho
DK126388A (da)	1988-05-10	Referenceelektrode
TR24110A (tr)	1991-03-20	Belirli suebstitue edilmis 3-amino-2-benzoil sikloheks-2-enonlar
AT386436B (de)	1988-08-25	Schachtsystem
ATA48386A (de)	1988-08-15	Kranbahn
DK554986D0 (da)	1986-11-19	Antistof
DK554886D0 (da)	1986-11-19	Antistoffer
DK348888D0 (da)	1988-06-24	Antistoffer
DK353288D0 (da)	1988-06-27	Antistoffer
BR8603538A (pt)	1987-03-31	Fecho
ATA179487A (de)	1990-12-15	Maishaecksler
BR6600236U (pt)	1987-10-06	Fecho
BR6601005U (pt)	1988-02-23	Fecho
BR8605861A (pt)	1988-06-28	Fecho
KR880010395U (ko)	1988-07-27	복합천기교습기
BR6600559U (pt)	1987-12-01	Mini-tripe
BR6601164U (pt)	1988-04-05	Poster-postal
BR6601281U (pt)	1987-03-10	Aeromodelo
BR6600495U (pt)	1987-11-10	Micro-fragmentadora
BR6600467U (pt)	1987-11-10	Antiassalt
BR6600378U (pt)	1987-11-03	Agenda-calendario
BR6600356U (pt)	1987-10-27	Dadotenis
BR6600239U (pt)	1987-10-13	Condutivimetro

Legal Events

Date	Code	Title	Description
1993-03-29	AHB	Application shelved due to non-payment